Brain neuronal CB2 cannabinoid receptors in drug abuse and depression: from mice to human subjects

The rat brain in stereotaxic coordinates

Palkovits, M. (1983) · Neuropeptides · doi:10.1016/0143-4179(83)90049-5 · Cited by 28,959 · see citing works

The Rat Brain in Stereotaxic Coordinates

Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585 · see citing works

THE USE OF LEAD CITRATE AT HIGH pH AS AN ELECTRON-OPAQUE STAIN IN ELECTRON MICROSCOPY

Reynolds, E. S. (1963) · The Journal of Cell Biology · doi:10.1083/jcb.17.1.208 · Cited by 24,938 · see citing works

Molecular characterization of a peripheral receptor for cannabinoids

Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092 · see citing works

Expression of Central and Peripheral Cannabinoid Receptors in Human Immune Tissues and Leukocyte Subpopulations

Galiègue, S., Mary, S., Marchand, J., Dussossoy, D., Carrière, D., Carayon, P., Bouaboula, M., Shire, D. J., Fur, G. L., & Casellas, P. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20780.x · Cited by 1,751 · see citing works

Chronic Mild Stress (CMS) Revisited: Consistency and Behavioural-Neurobiological Concordance in the Effects of CMS

Willner, P. (2005) · Neuropsychobiology · doi:10.1159/000087097 · Cited by 1,605 · see citing works

Identification and Functional Characterization of Brainstem Cannabinoid CB₂Receptors

Van Sickle, M. D., Duncan, M., Kingsley, P. J., Mouihate, A., Urbani, P., Mackie, K., Stella, N., Makriyannis, A., Piomelli, D., Davison, J. S., et al. (2005) · Science · doi:10.1126/science.1115740 · Cited by 1,470 · see citing works

Cannabis use and mental health in young people: cohort study.

Patton, G. C., Coffey, C., Carlin, J. B., Degenhardt, L., Lynskey, M., & Hall, W. (2002) · BMJ · doi:10.1136/bmj.325.7374.1195 · Cited by 997 · see citing works

Cannabinoid CB2 receptors: immunohistochemical localization in rat brain

Gong, J.-P., Onaivi, E. S., Ishiguro, H., Liu, Q.-R., Tagliaferro, P. A., Brusco, A., & Uhl, G. R. (2006) · Brain Research · doi:10.1016/j.brainres.2005.11.035 · Cited by 820 · see citing works

Cannabinoid CB2Receptors and Fatty Acid Amide Hydrolase Are Selectively Overexpressed in Neuritic Plaque-Associated Glia in Alzheimer's Disease Brains

Benito, C., Núñez, E., Tolón, R. M., Carrier, E. J., Rábano, A., Hillard, C. J., & Romero, J. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-35-11136.2003 · Cited by 624 · see citing works

Discovery of the Presence and Functional Expression of Cannabinoid CB2 Receptors in Brain

Onaivi, E. S., Ishiguro, H., GONG, J., Sejal, P., Perchuk, A., Meozzi, P. A., MYERS, L., Mora, Z., Tagliaferro, P. A., Gardner, E., et al. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1369.052 · Cited by 546 · see citing works

Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB2 receptor

Buckley, N. E., McCoy, K. L., Mezey, É., Bonner, T. I., Zimmer, A. M., Felder, C. C., Glass, M., & Zimmer, A. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00211-9 · Cited by 544 · see citing works

Activation of CB ₂ cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS

Ibrahim, M. M., Deng, H., Zvonok, A., Cockayne, D. A., Kwan, J., Mata, H. P., Vanderah, T. W., Lai, J., Porreca, F., Makriyannis, A., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834309100 · Cited by 491 · see citing works

Cannabis Abuse as a Risk Factor for Depressive Symptoms

BOVASSO, G. B. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.2033 · Cited by 455 · see citing works

Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation

Ehrhart, J. C., Obregon, D. F., Mori, T., Hou, H., Sun, N., Bai, Y., Klein, T., Fernandez, F., Tan, J., & Shytle, R. D. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-29 · Cited by 379 · see citing works

Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: An immunohistochemical study

Núñez, E., Benito, C., Pazos, M. R., Barbáchano, A., Fajardo, O., González, S. R., Tolón, R. M., & Romero, J. (2004) · Synapse · doi:10.1002/syn.20050 · Cited by 334 · see citing works

Alcohol, cannabis and tobacco use among Australians: a comparison of their associations with other drug use and use disorders, affective and anxiety disorders, and psychosis

Degenhardt, L. J., Hall, W., & Lynskey, M. T. (2001) · Addiction · doi:10.1046/j.1360-0443.2001.961116037.x · Cited by 330 · see citing works

Pharmacological characterization of cannabinoids in the elevated plus maze.

Onaivi, E. S., Green, M. R., & Martin, B. R. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13195-9 · Cited by 312 · see citing works

CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms

Beltramo, M., Bernardini, N., Bertorelli, R., Campanella, M., Nicolussi, E., Fredduzzi, S., & Reggiani, A. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04684.x · Cited by 290 · see citing works

Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy

Valenzano, K. J., Tafesse, L., Lee, G., Harrison, J. E., Boulet, J. M., Gottshall, S. L., Mark, L., Pearson, M. S., Miller, W., Shan, S., et al. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.12.008 · Cited by 288 · see citing works

Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors

Golech, S., McCarron, R. M., Chen, Y., Bembry, J., Lenz, F. A., Mechoulam, R., Shohami, E., & Spatz, M. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.08.025 · Cited by 248 · see citing works

Human cannabinoid receptor 1: 5′ exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse

Zhang, P. J., Ishiguro, H., Ohtsuki, T., Hess, J., Carillo, F., Walther, D. M., Onaivi, E. S., Arinami, T., & Uhl, G. R. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001560 · Cited by 247 · see citing works

Synthetic cannabinoid WIN55,212‐2 inhibits generation of inflammatory mediators by IL‐1β‐stimulated human astrocytes

Sheng, W. S., Hu, S., Min, X. M., Cabral, G. A., Lokensgard, J. R., & Peterson, P. K. (2004) · Glia · doi:10.1002/glia.20108 · Cited by 246 · see citing works

Drugs and alcohol: Treating and preventing abuse, addiction and their medical consequences

Volkow, N. D., & Li, T. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.06.021 · Cited by 239 · see citing works

Cannabinoid receptor type 2 gene is associated with human osteoporosis

Karsak, M., Cohen-Solal, M. E., Freudenberg, J., Ostertag, A., Morieux, C., Kornak, U., Essig, J., Erxlebe, E., Bab, I., Kubisch, C., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi370 · Cited by 218 · see citing works

Expression of the cannabinoid CB2 receptor in the rat cerebellum: An immunohistochemical study

Ashton, J. C., Friberg, D., Darlington, C. L., & Smith, P. F. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.11.038 · Cited by 208 · see citing works

A Glial Endogenous Cannabinoid System Is Upregulated in the Brains of Macaques with Simian Immunodeficiency Virus-Induced Encephalitis

Benito, C., Kim, W.-K., Chavarría, I., Hillard, C. J., Mackie, K., Tolón, R. M., Williams, K., & Romero, J. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3923-04.2005 · Cited by 163 · see citing works

Evaluation of the cannabinoid CB2 receptor-selective antagonist, SR144528: further evidence for cannabinoid CB2 receptor absence in the rat central nervous system

Griffin, G., Wray, E. J., Tao, Q., McAllister, S. D., Rorrer, W. K., Aung, M. M., Martin, B. R., & Abood, M. E. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00402-1 · Cited by 148 · see citing works

Involvement of cannabinoid CB2 receptor in alcohol preference in mice and alcoholism in humans

Ishiguro, H., Iwasaki, S., Teasenfitz, L., Higuchi, S., Horiuchi, Y., Saito, T., Arinami, T., & Onaivi, E. S. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500431 · Cited by 140 · see citing works

Role of the endocannabinoid system in depression and suicide

Vinod, K. Y., & Hungund, B. L. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.08.006 · Cited by 132 · see citing works

Targeting dopamine D2 and cannabinoid‐1 (CB1) receptors in rat nucleus accumbens

Pickel, V. M., Chan, J., Kearn, C. S., & Mackie, K. (2006) · The Journal of Comparative Neurology · doi:10.1002/cne.20881 · Cited by 128 · see citing works

Reduced endocannabinoid immune modulation by a common cannabinoid 2 (CB2) receptor gene polymorphism: possible risk for autoimmune disorders

Sipe, J. C., Arbour, N., Gerber, A., & Beutler, E. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0205111 · Cited by 126 · see citing works

Endocannabinoids

(2005) · CRC Press eBooks · doi:10.1201/9781420023640 · Cited by 54 · see citing works

CB2 Cannabinoid Receptors in Trabecular Meshwork Cells Mediate JWH015-Induced Enhancement of Aqueous Humor Outflow Facility

Zhong, L., Geng, L., Mbye, Y. F. N., Feng, W., & Song, Z.-H. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.04-0651 · Cited by 51 · see citing works

Role of endocannabinoid system in mental diseases

Manzanares, J., Urigüen, L., Rubio, G., & Palomo, T. (2004) · Neurotoxicity Research · doi:10.1007/bf03033223 · Cited by 49 · see citing works

Methods to Study the Behavioral Effects and Expression of CB2 Cannabinoid Receptor and Its Gene Transcripts in the Chronic Mild Stress Model of Depression

Onaivi, E. S., Ishiguro, H., Sejal, P., Meozzi, P. A., Myers, L., Tagliaferro, P. A., Hope, B. T., Leonard, C. M., Uhl, G. R., & Brusco, A. (2006) · Humana Press eBooks · doi:10.1385/1-59259-999-0:291 · Cited by 43 · see citing works

CB 1 - and CB 2 -cannabinoid receptor-independent lipolysis induced by WIN 55,212-2 in male rat adipocytes

Nieri, P., Greco, R., Adinolfi, B., Breschi, M. C., Martinotti, E., Nannetti, C., & Podest�, A. (2003) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-003-0831-3 · Cited by 18 · see citing works

The endocannabinoid system and the brain.

Mechoulam, R., & Parker, L. A. (2013) · Annual Review of Psychology · doi:10.1146/annurev-psych-113011-143739 · Cited by 1,090 · see citing works

Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications

Castaneto, M. S., Gorelick, D. A., Desrosiers, N. A., Hartman, R. L., Pirard, S., & Huestis, M. A. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.08.005 · Cited by 710 · see citing works

CB2: a cannabinoid receptor with an identity crisis

Atwood, B. K., & Mackie, K. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00729.x · Cited by 633 · see citing works

Cannabinoid and cannabinoid‐like receptors in microglia, astrocytes, and astrocytomas

Stella, N. (2010) · Glia · doi:10.1002/glia.20983 · Cited by 529 · see citing works

Spice drugs are more than harmless herbal blends: A review of the pharmacology and toxicology of synthetic cannabinoids

Seely, K. A., Lapoint, J. M., Moran, J. H., & Fattore, L. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.04.017 · Cited by 463 · see citing works

CB 1 and CB 2 Receptor Pharmacology

Howlett, A. C., & Abood, M. E. (2017) · Advances in pharmacology · doi:10.1016/bs.apha.2017.03.007 · Cited by 385 · see citing works

Cannabis Pharmacology: The Usual Suspects and a Few Promising Leads

Russo, E. B., & Marcu, J. P. (2017) · Advances in pharmacology · doi:10.1016/bs.apha.2017.03.004 · Cited by 379 · see citing works

The endocannabinoid system: Its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation

Marzo, V. D. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.02.010 · Cited by 367 · see citing works

Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders

Iannotti, F. A., Marzo, V. D., & Petrosino, S. (2016) · Progress in Lipid Research · doi:10.1016/j.plipres.2016.02.002 · Cited by 357 · see citing works

Endocannabinoid signaling in microglial cells

Stella, N. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.037 · Cited by 271 · see citing works

Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ9-THC: Mechanism underlying greater toxicity?

Fantegrossi, W. E., Moran, J. H., Radominska-p, A., & Prather, P. L. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.09.017 · Cited by 261 · see citing works

An introduction to the endocannabinoid system: from the early to the latest concepts

PETROCELLIS, L. D., & Marzo, V. D. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.10.013 · Cited by 249 · see citing works

Species differences in cannabinoid receptor 2 (CNR2gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands

Liu, Q., Pan, C., Hishimoto, A., Li, C., Xi, Z., Llorente‐Berzal, A., Viveros, M., Ishiguro, H., Arinami, T., Onaivi, E. S., et al. (2009) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2009.00498.x · Cited by 248 · see citing works

The endocannabinoid system as a target for novel anxiolytic drugs

Patel, S., Hill, M. N., Cheer, J. F., Wotjak, C. T., & Holmes, A. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.12.033 · Cited by 233 · see citing works

Detection and Activity Profiling of Synthetic Cannabinoids and Their Metabolites with a Newly Developed Bioassay

Cannaert, A., Storme, J., Franz, F., Auwärter, V., & Stove, C. P. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.6b02600 · Cited by 223 · see citing works

Endocannabinoid system and mood disorders: Priming a target for new therapies

Micale, V., Marzo, V. D., Šulcová, A., Wotjak, C. T., & Drago, F. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.12.002 · Cited by 222 · see citing works

Endocannabinoid Binding to the Cannabinoid Receptors: What Is Known and What Remains Unknown

Reggio, P. H. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790980005 · Cited by 212 · see citing works

Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR

Wong, D. F., Kuwabara, H., Horti, A. G., Raymont, V., Brašić, J. R., Guevara, M. C., Ye, W., Dannals, R. F., Ravert, H. T., Nandi, A., et al. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.04.034 · Cited by 204 · see citing works

Progress in brain cannabinoid CB2 receptor research: From genes to behavior

Jordan, C. J., & Xi, Z. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.12.026 · Cited by 197 · see citing works

Depression‐resistant endophenotype in mice overexpressing cannabinoid CB ₂ receptors

García‐Gutiérrez, M., Pérez‐Ortiz, J., Gutiérrez‐Adán, A., & Manzanares, J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00819.x · Cited by 196 · see citing works

Cannabinoids and Pain: Sites and Mechanisms of Action

Starowicz, K., & Finn, D. P. (2017) · Advances in pharmacology · doi:10.1016/bs.apha.2017.05.003 · Cited by 192 · see citing works

Brain Cannabinoid CB2 Receptor in Schizophrenia

Ishiguro, H., Horiuchi, Y., Ishikawa, M., Koga, M., Imai, K., Suzuki, Y., Morikawa, M., Inada, T., Watanabe, Y., Takahashi, M., et al. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.024 · Cited by 184 · see citing works

Neurobiological consequences of maternal cannabis on human fetal development and its neuropsychiatric outcome

Jutras‐Aswad, D., DiNieri, J. A., Harkany, T., & Hurd, Y. L. (2009) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-009-0027-z · Cited by 184 · see citing works

Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors

Serrano, A., & Parsons, L. H. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.06.005 · Cited by 180 · see citing works

CB2 Receptor in Microglia: The Guardian of Self-Control

Komorowska‐Müller, J. A., & Schmöle, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010019 · Cited by 167 · see citing works

Activation of Cannabinoid CB2 Receptor–Mediated AMPK/CREB Pathway Reduces Cerebral Ischemic Injury

Choi, I.-Y., Ju, C., Jalin, A. M. A. A., Lee, D. I., Prather, P. L., & Kim, W.-K. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.11.024 · Cited by 157 · see citing works

Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice

García-Gutiérrez, M. S., & Manzanares, J. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110379507 · Cited by 153 · see citing works

The Polypharmacological Effects of Cannabidiol

Castillo-Arellano, J. I., Canseco-Alba, A., Cutler, S. J., & León, F. (2023) · Molecules · doi:10.3390/molecules28073271 · Cited by 163 · see citing works

Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference

Liu, Q.-R., Canseco-Alba, A., Zhang, H.-Y., Tagliaferro, P., Chung, M., Dennis, E., Sanabria, B., Schanz, N., Escosteguy-Neto, J. C., Ishiguro, H., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-17796-y · Cited by 147 · see citing works

Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders

Navarro, G., Morales, P., Rodríguez‐Cueto, C., Fernández‐Ruíz, J., Jagerovic, N., & Franco, R. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00406 · Cited by 147 · see citing works

Neuronal expression of CB2 cannabinoid receptor mRNAs in the mouse hippocampus

Li, Y., & Kim, J. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.10.041 · Cited by 146 · see citing works

Cannabinoid Receptors: An Update on Cell Signaling, Pathophysiological Roles and Therapeutic Opportunities in Neurological, Cardiovascular, and Inflammatory Diseases

Haspula, D., & Clark, M. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207693 · Cited by 137 · see citing works

Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects

Marco, E. M. (2011) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00063 · Cited by 136 · see citing works

Chronic blockade of cannabinoid CB2receptors induces anxiolytic‐like actions associated with alterations in GABAAreceptors

García‐Gutiérrez, M. S., García‐Bueno, B., Zoppi, S., Leza, J. C., & Manzanares, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01625.x · Cited by 136 · see citing works

Endocannabinoid System Components as Potential Biomarkers in Psychiatry

Navarrete, F., García‐Gutiérrez, M. S., Barba, R. J., Rubio, G., Gasparyan, A., Austrich-Olivares, A., & Manzanares, J. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00315 · Cited by 134 · see citing works

Endocannabinoid System Components: Overview and Tissue Distribution

Joshi, N., & Onaivi, E. S. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-21737-2_1 · Cited by 132 · see citing works

Candidate genes for cannabis use disorders: findings, challenges and directions.

Agrawal, A., & Lynskey, M. T. (2009) · Addiction · doi:10.1111/j.1360-0443.2009.02504.x · Cited by 128 · see citing works

Neuroprotective and Immunomodulatory Action of the Endocannabinoid System under Neuroinflammation

Kasatkina, L. A., Rittchen, S., & Sturm, E. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115431 · Cited by 129 · see citing works

Pharmacological and Toxicological Effects of Synthetic Cannabinoids and Their Metabolites

Tai, S., & Fantegrossi, W. E. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_60 · Cited by 127 · see citing works

Synaptic plasticity alterations associated with memory impairment induced by deletion of CB2 cannabinoid receptors

García‐Gutiérrez, M. S., Ortega-Álvaro, A., Busquets-García, A., Pérez‐Ortiz, J. M., Caltana, L. R., Ricatti, M. J., Brusco, A., Maldonado, R. J., & Manzanares, J. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.034 · Cited by 126 · see citing works

Role of CB2 Cannabinoid Receptors in the Rewarding, Reinforcing, and Physical Effects of Nicotine

Navarrete, F., Rodríguez‐Arias, M., Martín‐García, E., Navarro, D., García‐Gutiérrez, M. S., Aguilar, M. A., Aracil-Fernández, A., Berbel, P. J., Miñarro, J., Maldonado, R. J., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.157 · Cited by 121 · see citing works

Cannabidiol decreases body weight gain in rats: Involvement of CB2 receptors

Ignatowska-Jankowska, B. M., Jankowski, M. M., & Swiergiel, A. H. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.12.031 · Cited by 119 · see citing works

The cannabinoid receptor 2 agonist, β-caryophyllene, reduced voluntary alcohol intake and attenuated ethanol-induced place preference and sensitivity in mice

Mansouri, S. A., Ojha, S. K., Maamari, E. A., Ameri, M. A., Nurulain, S. M., & Bahí, A. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.06.025 · Cited by 119 · see citing works

Decreased Cocaine Motor Sensitization and Self-Administration in Mice Overexpressing Cannabinoid CB2 Receptors

Aracil-Fernández, A., Trigo, J. M., García‐Gutiérrez, M. S., Ortega-Álvaro, A., Ternianov, A., Navarro, D., Robledo, P., Berbel, P. J., Maldonado, R. J., & Manzanares, J. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.22 · Cited by 119 · see citing works

Putative role of endocannabinoid signaling in the etiology of depression and actions of antidepressants

Gorzalka, B. B., & Hill, M. N. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.11.021 · Cited by 118 · see citing works

Role of the endocannabinoid system in drug addiction

Manzanares, J., Cabañero, D., Puente, N., García‐Gutiérrez, M. S., Grandes, P., & Maldonado, R. J. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.09.013 · Cited by 116 · see citing works

The endocannabinoid system and the regulation of neural development: potential implications in psychiatric disorders

Galve‐Roperh, I., Palazuelos, J., Aguado, T., & Guzmán, M. (2009) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-009-0028-y · Cited by 110 · see citing works

Brain activity of anandamide: a rewarding bliss?

Scherma, M., Masia, P., Satta, V., Fratta, W., Fadda, P., & Tanda, G. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0075-x · Cited by 105 · see citing works

Identification of CB2 receptors in human nigral neurons that degenerate in Parkinson’s disease

García, M. C., Cinquina, V., Palomo‐Garo, C., Rábano, A., & Fernández‐Ruíz, J. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.12.003 · Cited by 105 · see citing works

Endocannabinoid System: the Direct and Indirect Involvement in the Memory and Learning Processes—a Short Review

Kruk-Słomka, M., Dzik, A., Budzyńska, B., & Biała, G. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0313-5 · Cited by 107 · see citing works

Chronic activation of CB2 cannabinoid receptors in the hippocampus increases excitatory synaptic transmission

Kim, J., & Li, Y. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2014.286633 · Cited by 99 · see citing works

Endocannabinoid System: Emerging Role from Neurodevelopment to Neurodegeneration

Basavarajappa, B. S., Nixon, R. A., & Arancio, O. (2009) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955709787847921 · Cited by 96 · see citing works

Endocannabinoids via CB 1 receptors act as neurogenic niche cues during cortical development

Díaz-Alonso, J., Guzmán, M., & Galve‐Roperh, I. (2012) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0385 · Cited by 94 · see citing works

Endocannabinoid-mediated synaptic plasticity and addiction-related behavior

Sidhpura, N., & Parsons, L. H. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.05.034 · Cited by 92 · see citing works

CB2 Cannabinoid Receptor Knockout in Mice Impairs Contextual Long-Term Memory and Enhances Spatial Working Memory

Li, Y., & Kim, J. (2015) · Neural Plasticity · doi:10.1155/2016/9817089 · Cited by 90 · see citing works

Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors

Rajasekaran, M., Brents, L. K., Franks, L. N., Moran, J. H., & Prather, P. L. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.03.012 · Cited by 90 · see citing works

Cannabinoid-related Agents in the Treatment of Anxiety Disorders: Current Knowledge and Future Perspectives

Tambaro, S., & Bortolato, M. (2011) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488912798842269 · Cited by 89 · see citing works

Functional Selectivity of CB2 Cannabinoid Receptor Ligands at a Canonical and Noncanonical Pathway

Dhopeshwarkar, A., & Mackie, K. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.232561 · Cited by 88 · see citing works

Endocannabinoid-mediated modulation of stress responses: Physiological and pathophysiological significance

Finn, D. P. (2009) · Immunobiology · doi:10.1016/j.imbio.2009.05.011 · Cited by 88 · see citing works

Therapeutics for neonatal brain injury

Gonzalez, F. F., & Ferriero, D. M. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.07.003 · Cited by 87 · see citing works

Managing Chronic Pain in the Elderly: An Overview of the Recent Therapeutic Advancements

Asad, A., Arif, A. W., Bhan, C., Kumar, D., Malik, M. B., Sayyed, Z., Akhtar, K. H., & Ahmad, M. Q. (2018) · Cureus · doi:10.7759/cureus.3293 · Cited by 89 · see citing works

The cannabinoid CB2 receptor is necessary for nicotine-conditioned place preference, but not other behavioral effects of nicotine in mice

Ignatowska-Jankowska, B. M., Muldoon, P. P., Lichtman, A. H., & Damaj, M. I. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3117-6 · Cited by 83 · see citing works

Brain CB2 Receptors: Implications for Neuropsychiatric Disorders

Roche, M., & Finn, D. P. (2010) · Pharmaceuticals · doi:10.3390/ph3082517 · Cited by 87 · see citing works

Role of cannabinoid CB2receptor in the reinforcing actions of ethanol

Ortega-Álvaro, A., Ternianov, A., Aracil-Fernández, A., Navarrete, F., García‐Gutiérrez, M. S., & Manzanares, J. (2013) · Addiction Biology · doi:10.1111/adb.12076 · Cited by 83 · see citing works

Reviewing the Role of the Endocannabinoid System in the Pathophysiology of Depression

Gallego‐Landin, I., García-Baos, A., Castro‐Zavala, A., & Valverde, O. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.762738 · Cited by 84 · see citing works

The cannabinoid CB 1 receptor and the endocannabinoid anandamide: possible antidepressant targets

Bambico, F. R., & Gobbi, G. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.11.1347 · Cited by 80 · see citing works

Distinct roles of neuronal and microglial CB2 cannabinoid receptors in the mouse hippocampus

Li, Y., & Kim, J. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.08.053 · Cited by 78 · see citing works

The endocannabinoid system in mental disorders: Evidence from human brain studies

Ibarra‐Lecue, I., Pilar-Cuéllar, F., Muguruza, C., Florensa-Zanuy, E., Díaz, Á., Urigüen, L., Castro, E., Pazos, Á., & Callado, L. F. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.07.009 · Cited by 80 · see citing works

Deletion of CB 2 cannabinoid receptors reduces synaptic transmission and long‐term potentiation in the mouse hippocampus

Li, Y., & Kim, J. (2015) · Hippocampus · doi:10.1002/hipo.22558 · Cited by 77 · see citing works

CB2: Therapeutic target-in-waiting

Atwood, B. K., Straiker, A. J., & Mackie, K. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.12.001 · Cited by 76 · see citing works

Neuroprotection in the Newborn Infant

Gonzalez, F. F., & Ferriero, D. M. (2009) · Clinics in Perinatology · doi:10.1016/j.clp.2009.07.013 · Cited by 73 · see citing works

Chemistry of Cannabis

Hazekamp, A., Fischedick, J. T., Díez, M. L., Lubbe, A., & Ruhaak, L. R. (2010) · Elsevier eBooks · doi:10.1016/b978-008045382-8.00091-5 · Cited by 76 · see citing works

Cannabinoid CB2 receptor‐mediated regulation of impulsive‐like behaviour in DBA/2 mice

Navarrete, F., Pérez‐Ortiz, J. M., & Manzanares, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01542.x · Cited by 72 · see citing works

Pro-psychotic effects of synthetic cannabinoids: interactions with central dopamine, serotonin, and glutamate systems

Fantegrossi, W. E., Wilson, C. D., & Berquist, M. D. (2018) · Drug Metabolism Reviews · doi:10.1080/03602532.2018.1428343 · Cited by 73 · see citing works

Role of the endocannabinoid system in vertebrates: Emphasis on the zebrafish model

Oltrabella, F., Melgoza, A., Nguyen, B., & Guo, S. (2017) · Development Growth & Differentiation · doi:10.1111/dgd.12351 · Cited by 72 · see citing works

Cannabinoid Receptors in Brain

Onaivi, E. S. (2009) · International review of neurobiology · doi:10.1016/s0074-7742(09)88012-4 · Cited by 71 · see citing works

Neuronal populations mediating the effects of endocannabinoids on stress and emotionality

Häring, M., Guggenhuber, S., & Lutz, B. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2011.12.035 · Cited by 70 · see citing works

Endocannabinoids and Mental Disorders

Rubino, T., Zamberletti, E., & Parolaro, D. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-20825-1_9 · Cited by 71 · see citing works

CB2 receptor in the CNS: From immune and neuronal modulation to behavior

Grabon, W., Rheims, S., Smith, J., Bodennec, J., Belmeguenaï, A., & Bezin, L. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105226 · Cited by 67 · see citing works

Crosstalk between endocannabinoid and immune systems: a potential dysregulation in depression?

Boorman, E., Zajkowska, Z., Ahmed, R., Pariante, C. M., & Zunszain, P. A. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4105-9 · Cited by 66 · see citing works

Effects of a Selective Cannabinoid CB2 Agonist and Antagonist on Intravenous Nicotine Self Administration and Reinstatement of Nicotine Seeking

Gamaleddin, I., Zvonok, A. M., Makriyannis, A., Goldberg, S. R., & Foll, B. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029900 · Cited by 66 · see citing works

Antidepressant-like effects of β-caryophyllene on restraint plus stress-induced depression

Hwang, E., Kim, H.-B., Lee, S., Kim, M. J., Kim, K.-J., Han, G., Han, S.-Y., Lee, E.-A., Yoon, J.-H., Kim, D., et al. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112439 · Cited by 67 · see citing works

A nonsynonymous polymorphism in cannabinoid CB2 receptor gene is associated with eating disorders in humans and food intake is modified in mice by its ligands

Ishiguro, H., Carpio, O., Horiuchi, Y., Shu, A., Higuchi, S., Schanz, N., Benno, R. H., Arinami, T., & Onaivi, E. S. (2009) · Synapse · doi:10.1002/syn.20714 · Cited by 66 · see citing works

Similar anxiolytic effects of agonists targeting serotonin 5-HT1A or cannabinoid CB receptors on zebrafish behavior in novel environments

Connors, K. A., Valenti, T. W., Lawless, K., Sackerman, J., Onaivi, E. S., Brooks, B. W., & Gould, G. G. (2013) · Aquatic Toxicology · doi:10.1016/j.aquatox.2013.12.005 · Cited by 66 · see citing works

The endocannabinoid system in the regulation of emotions throughout lifespan: a discussion on therapeutic perspectives

Marco, E. M., & Laviola, G. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111408459 · Cited by 65 · see citing works

Alterations in Gene and Protein Expression of Cannabinoid CB2 and GPR55 Receptors in the Dorsolateral Prefrontal Cortex of Suicide Victims

García‐Gutiérrez, M. S., Navarrete, F., Navarro, G., Reyes‐Resina, I., Franco, R., Lanciego, J. L., Giner, S., & Manzanares, J. (2018) · Neurotherapeutics · doi:10.1007/s13311-018-0610-y · Cited by 65 · see citing works

New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders

Kibret, B. G., Ishiguro, H., Horiuchi, Y., & Onaivi, E. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020975 · Cited by 63 · see citing works

The cannabinoid system and visual processing: A review on experimental findings and clinical presumptions

Schwitzer, T., Schwan, R., Angioï-Duprez, K., Ingster-Moati, I., Lalanne, L., Giersch, A., & Laprévote, V. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.11.002 · Cited by 61 · see citing works

Genetic association between bipolar disorder and 524A>C (Leu133Ile) polymorphism of CNR2 gene, encoding for CB2 cannabinoid receptor

Minocci, D., Massei, J., Martino, A., Milianti, M., Piz, L., Bello, D. D., Sbrana, A., Martinotti, E., Rossi, A. M., & Nieri, P. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.05.023 · Cited by 61 · see citing works

Latest Advances in Novel Cannabinoid Cb2Ligands for Drug Abuse and Their Therapeutic Potential

Yang, P., Wang, L., & Xie, X.-Q. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.11.179 · Cited by 60 · see citing works

Regulation of Brain Reward by the Endocannabinoid System: A Critical Review of Behavioral Studies in Animals

Vlachou, S., & Panagis, G. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990433 · Cited by 60 · see citing works

Overexpression of CB2 cannabinoid receptors results in neuroprotection against behavioral and neurochemical alterations induced by intracaudate administration of 6-hydroxydopamine

Ternianov, A., Pérez‐Ortiz, J. M., Solesio, M. E., García‐Gutiérrez, M. S., Ortega-Álvaro, A., Navarrete, F., Leiva, C., Galindo, M. F., & Manzanares, J. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.09.012 · Cited by 59 · see citing works

Behavioral effects of psychostimulants in mutant mice with cell-type specific deletion of CB2 cannabinoid receptors in dopamine neurons

Canseco-Alba, A., Schanz, N., Sanabria, B., Zhao, J., Lin, Z., Liu, Q., & Onaivi, E. S. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.11.043 · Cited by 59 · see citing works

Role of the endogenous cannabinoid system in nicotine addiction: novel insights

Gamaleddin, I. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00041 · Cited by 58 · see citing works

Synthesis, in vitro and in vivo evaluation of fluorine-18 labelled FE-GW405833 as a PET tracer for type 2 cannabinoid receptor imaging

Evens, N., Vandeputte, C., Muccioli, G. G., Lambert, D. M., Baekelandt, V., Verbruggen, A., Debyser, Z., Laere, K. V., & Bormans, G. M. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.06.033 · Cited by 56 · see citing works

Functional consequences of nonsynonymous single nucleotide polymorphisms in the CB2 cannabinoid receptor

Carrasquer, A., Nebane, N. M., Williams, W. M., & Song, Z.-H. (2010) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3283367c6b · Cited by 56 · see citing works

Cannabinoid receptor agonists upregulate and enhance serotonin 2A (5‐HT2A) receptor activity via ERK1/2 signaling

Franklin, J. M., & Carrasco, G. A. (2012) · Synapse · doi:10.1002/syn.21626 · Cited by 56 · see citing works

Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives

Scherma, M., Muntoni, A. L., Melis, M., Fattore, L., Fadda, P., Fratta, W., & Pistis, M. (2016) · Psychopharmacology · doi:10.1007/s00213-015-4196-3 · Cited by 57 · see citing works

The Endocannabinoid System and Anxiety

Lisboa, S. F. D. S., Gomes, F. V., Terzian, A. L. B., de Aguiar, D. C., Moreira, F. A., Resstel, L. B. M., & Guimarães, F. S. (2016) · Vitamins and hormones · doi:10.1016/bs.vh.2016.09.006 · Cited by 56 · see citing works

Cannabinoids in depressive disorders

Poleszak, E., Wośko, S., Sławińska, K., Szopa, A., Wróbel, A., & Serefko, A. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.09.058 · Cited by 55 · see citing works

Functional Expression of Brain Neuronal CB2 Cannabinoid Receptors Are Involved in the Effects of Drugs of Abuse and in Depression

Onaivi, E. S., Ishiguro, H., Gong, J., Sejal, P., Meozzi, P. A., Myers, L., Perchuk, A., Mora, Z., Tagliaferro, P. A., Gardner, E., et al. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1432.036 · Cited by 178 · see citing works

Methods to Study the Behavioral Effects and Expression of CB2 Cannabinoid Receptor and Its Gene Transcripts in the Chronic Mild Stress Model of Depression

Onaivi, E. S., Ishiguro, H., Sejal, P., Meozzi, P. A., Myers, L., Tagliaferro, P. A., Hope, B. T., Leonard, C. M., Uhl, G. R., & Brusco, A. (2006) · Humana Press eBooks · doi:10.1385/1-59259-999-0:291 · Cited by 43 · see citing works

Methos to study the behavioral effects and expression of CB2 cannabinoid receptors and its gene transcripts in chronic mild stress model of depression

Onaiv, E. S., Ishiguro, H., Sejal, P., Meozzi, P. A., Myers, L. H., Tagliaferro, P. A., Hope, B. T., Leonard, C. M., Uhl, G. R., Brusco, H. A., et al. (2006) · Conicet

Neuropsychobiological Evidence for the Functional Presence and Expression of Cannabinoid CB2 Receptors in the Brain

Onaivi, E. S. (2006) · Neuropsychobiology · doi:10.1159/000100778 · Cited by 187 · see citing works

CNS Effects of CB2 Cannabinoid Receptors

Onaivi, E. S., Ishiguro, H., Liu, Q., Gong, J.-P., Tagliaferro, P. A., Brusco, A., Arinami, T., & Uhl, G. R. (2009) · The Open Neuropsychopharmacology Journal · doi:10.2174/1876523800902020045 · Cited by 4 · see citing works